4月8日,德琪医药(06996)发布公告,公司计划进行市场内股份回购。根据2024年6月14日股东周年大会通过的决议,公司董事会决定行使股份回购授权,拟回购最多6749万股公司股份,约占当时已发行股份总数的10%。董事会于2025年4月7日已决议动用该授权,计划在市场条件下按最高总价4000万元港元回购股份。此次回购将使用公司的内部资源进行资金支持。董事会表示,此举反映出对公司业务前景的信心,预期...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.